|
Mechanismβ-adrenoceptors antagonists |
|
|
|
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Laboratoires Alcon SAS /Kayserberg Plant/
0 Patents (Medical) associated with Laboratoires Alcon SAS /Kayserberg Plant/
100 Deals associated with Laboratoires Alcon SAS /Kayserberg Plant/
100 Translational Medicine associated with Laboratoires Alcon SAS /Kayserberg Plant/